Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Operating Expenses (2016 - 2025)

INVO Fertility (IVF) has disclosed Operating Expenses for 15 consecutive years, with -$12.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses fell 557.84% to -$12.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $16.2 million, a 30.41% increase, with the full-year FY2024 number at $14.7 million, up 49.75% from a year prior.
  • Operating Expenses was -$12.5 million for Q3 2025 at INVO Fertility, down from $4.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $18.7 million in Q1 2025 to a low of -$12.5 million in Q3 2025.
  • A 5-year average of $3.0 million and a median of $2.7 million in 2022 define the central range for Operating Expenses.
  • Biggest YoY gain for Operating Expenses was 507.74% in 2025; the steepest drop was 557.84% in 2025.
  • INVO Fertility's Operating Expenses stood at $2.5 million in 2021, then rose by 19.98% to $3.0 million in 2022, then fell by 3.54% to $2.9 million in 2023, then skyrocketed by 78.19% to $5.2 million in 2024, then plummeted by 343.01% to -$12.5 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Operating Expenses are -$12.5 million (Q3 2025), $4.9 million (Q2 2025), and $18.7 million (Q1 2025).